IRIS
MARCHETTI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.431
EU - Europa 3.950
AS - Asia 2.457
SA - Sud America 176
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 11.047
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.401
SG - Singapore 1.023
CN - Cina 787
UA - Ucraina 700
IE - Irlanda 654
IT - Italia 615
SE - Svezia 460
GB - Regno Unito 421
TR - Turchia 394
DE - Germania 345
FR - Francia 320
FI - Finlandia 186
BR - Brasile 165
IN - India 132
RU - Federazione Russa 124
HK - Hong Kong 51
CZ - Repubblica Ceca 28
BE - Belgio 25
CA - Canada 22
NL - Olanda 19
AT - Austria 14
VN - Vietnam 12
EU - Europa 10
IL - Israele 9
TW - Taiwan 7
IR - Iran 6
JP - Giappone 6
GR - Grecia 5
MX - Messico 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
CO - Colombia 4
MY - Malesia 4
PL - Polonia 4
AU - Australia 3
ES - Italia 3
IQ - Iraq 3
KR - Corea 3
LT - Lituania 3
MA - Marocco 3
MK - Macedonia 3
NG - Nigeria 3
RO - Romania 3
UG - Uganda 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
KE - Kenya 2
LB - Libano 2
MN - Mongolia 2
NP - Nepal 2
BY - Bielorussia 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
Totale 11.047
Salva come PNG Salva come JPEG
Città #
Jacksonville 843
Chandler 823
Singapore 704
Dublin 645
Princeton 323
Southend 288
Izmir 239
Nanjing 239
Ashburn 169
Beijing 152
Santa Clara 143
Wilmington 137
Cambridge 132
Dearborn 120
Altamura 108
Munich 105
The Dalles 100
Ann Arbor 90
Boardman 89
Nanchang 71
Chieti 69
Helsinki 61
Pescara 59
Shenyang 55
Hong Kong 48
New York 45
Hebei 39
Los Angeles 39
Tianjin 39
Woodbridge 35
Rome 34
Kunming 31
Hangzhou 28
Grevenbroich 25
Washington 25
Milan 23
Norwalk 22
Brussels 21
Jiaxing 20
San Mateo 20
Augusta 18
Collecorvino 18
Brno 17
Orange 16
Toronto 15
Latina 13
Nuremberg 13
Changsha 12
Jinan 11
São Paulo 11
Vienna 11
Fairfield 10
Falls Church 10
London 10
Ningbo 10
Zhengzhou 10
Chicago 9
Dong Ket 9
Guangzhou 9
Lanzhou 9
Tappahannock 9
Ancona 8
Andover 8
Montesilvano 8
Olomouc 8
Varallo 8
Auburn Hills 7
Belo Horizonte 7
Romola 7
Seattle 7
Frankfurt am Main 6
Houston 6
Changchun 5
Chennai 5
Council Bluffs 5
Edinburgh 5
Leawood 5
Ottawa 5
Rio de Janeiro 5
Ascoli Piceno 4
Cavacurta 4
Florence 4
Hanover 4
Kuala Lumpur 4
Milazzo 4
New Delhi 4
Oslo 4
Verona 4
Brasília 3
Campinas 3
Civitanova Marche 3
Curitiba 3
Gloucester 3
Hefei 3
Jyväskylä 3
Kampala 3
Madrid 3
Mexico City 3
Porto Alegre 3
Reggio Emilia 3
Totale 6.695
Salva come PNG Salva come JPEG
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 226
Assessing EGFR mutations. 150
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 136
Validation of a new algorithm for a quick and easy RT-PCR-based ALK test in a large series of lung adenocarcinomas: Comparison with FISH, immunohistochemistry and next generation sequencing assays 135
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. 125
A multidisciplinary group for prostate cancer management: A single institution experience 123
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: Toward a real-time liquid biopsy for treatment 120
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: Results of the first italian external quality assurance scheme 116
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors 114
A unique microRNA signature associated with plaque instability in humans. 110
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. 108
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. 107
Why anti-PD1/PDL1 therapy is so effective? Another piece in the puzzle 107
A unique microRNA signature associated with ischemic stroke in humans 106
Analysis of DNA Glycosylases MUTYH and OGG1 and Their Correlation with EGFR Signalling in Normal and Nodular Thyroid Tissues 104
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 103
KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment. 103
Optimizing Single Agent Panitumumab Therapy in Pre-Treated Advanced Colorectal Cancer 103
ROS1 Gene Fusion in Advanced Lung Cancer in Women: A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 99
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 97
Down regulation of high in normal-1 (HIN-1) is a frequent event in stage I non-small cell lung cancer and correlates with poor clinical outcome. 97
Evaluation of DNA Base Excision Repair and ErbB signaling in euthyroid goiters 97
Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non–Small-cell Lung Cancer: Clinical and Budget Effect 95
HIGH-RISK HUMAN PAPILLOMA VIRUS INFECTION, TUMOR PATHOPHENOTYPES AND BRCA1/2 AND P53 STATUS IN JUVENILE BREAST CANCER PATIENTS. 93
Primary pleuro-pulmonary synovial sarcoma: a single-center 13-year experience 93
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 92
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. 89
AKT1(E17K) in human solid tumours 89
Survival prediction of stage I lung adenocarcinomas by expression of 10 genes. 89
Int6 expression can predict survival in early-stage non-small cell lung cancer patients. 89
Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma. 87
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 87
Alterations of P16 (MTS1) in node-positive non-small cell lung carcinomas. 86
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 85
The chromosomal location of the mouse mammary tumor gene Int6 and related pseudogenes in the mouse genome. 84
Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up 84
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization. 84
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 84
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. 84
p53 alterations in non-small cell lung cancer correlate with metastatic involvement of hilar and mediastinal lymph nodes 83
Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples. 83
Complex Mutations & Subpopulations of Deletions at Exon 19 of EGFR in NSCLC Revealed by Next Generation Sequencing: Potential Clinical Implications. 83
Lung tumours from non-smoking subjects: A p53-related genetic instability in a subset of cases. 82
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation 82
Absence of somatic mutations in the coding region of the waf1/cip1 gene in human breast, lung and ovarian carcinomas - a polymorphism at codon-31. 82
Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients 82
Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project 82
mdm2 gene alterations and mdm2 protein expression in breast carcinomas 81
Mutational profile of GNAQQ209 in human tumors. 81
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe 81
Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors. 80
Correspondence - In Reply - Limitations of Single-Strand Conformation Polymorphism Analysis As a High-Throughput Method for the Detection of EGFR Mutations in the Clinical Setting 80
The Integrated Oncology Program of the Italian Ministry of Health. Analytical and clinical validation of new biomarkers for early diagnosis: network, resources, methodology, quality control, and data analysis. 80
PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. 79
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: A new algorithm for patient selection and personalized treatment 79
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. 78
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies 78
Early prediction of response to tyrosine kinase inhibitors by quantification of EGFR mutations in plasma of NSCLC patients 77
PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy 77
Bronchioloalveolar carcinoma: K-ras mutations are constant events in the mucinous subtype 76
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung. 76
Association between cigarette smoking and FHIT gene alterations in lung cancer. 76
Telomerase activity as a prognostic indicator in Stage I Non- Small Cell Lung Cancer -Gruppo Italiano di Patologia Molecolare II Riunione Scientifica. Pisa 20-22 Giugno99 75
Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. 75
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. 75
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. 75
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. 75
The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. 73
Survivin gene expression in early-stage non-small cell lung cancer. 73
Computer-Based Intensity Measurement Assists Pathologists in Scoring Phosphatase and Tensin Homolog Immunohistochemistry — Clinical Associations in NSCLC Patients of the European Thoracic Oncology Platform Lungscape Cohort 73
Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. 72
Hypertension modulates miR-145 expression in human atherosclerotic plaques 72
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 72
Genetic analysis of lung tumors of non-smoking subject: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus 71
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. 71
Molecular profiling of the "plexinome" in melanoma and pancreatic cancer. 71
microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer. 71
2nd ESMO Consensus Conference in Lung Cancer: Locally advanced stage III non-small-cell lung cancer 71
Predictive markers in lung cancer: A few hints for the practicing pathologist 71
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. 71
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. 70
2nd ESMO consensus conference on lung cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up 70
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptations 70
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. 69
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments 69
Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. 68
p95HER2 Truncated Form in Resected Non-small Cell Lung Cancer. 68
Quantification of EGFR Mutations in Plasma of NSCLC Patients: An Early Predictor of Clinical Response to Tyrosine Kinase Inhibitor 68
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 68
K-ras mutations and cetuximab in colorectal cancer. 67
Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. 66
Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer 66
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones. 66
Evaluation of FHIT gene alterations in ovarian cancer 64
A percutaneous large-needle aspiration biopsy technique for histologic examination of the testis in infertile patients. 64
Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. 62
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. 62
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: Results from the ETOP Lungscape Project 62
POLE exonuclease domain mutations in endometrial carcinoma: a case report 61
Recommendations for mutational analysis of EGFR in lung carcinoma. 61
Totale 8.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020227 0 0 0 0 0 0 0 0 0 0 212 15
2020/2021933 182 15 172 7 76 189 20 10 79 130 9 44
2021/2022806 26 14 10 133 53 34 24 55 64 40 107 246
2022/20232.275 221 307 106 268 229 445 138 145 289 15 64 48
2023/20241.013 97 27 63 28 67 294 208 42 11 34 6 136
2024/20252.392 158 598 499 72 74 125 164 161 326 143 72 0
Totale 11.369